Data spanning the past 90 days through February 19, 2026 reveals that China Pharma Holdings's three principal insider shareholders consist of Ceo & Interim Cfo Zhilin Li (30.28K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Zhilin Li | Ceo & Interim Cfo | 30,276 | 19 Oct, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 29 Sep, 2023 | Zhilin Li | Common Stock | A | 13,757,063 | $0.14 | 30,276 | D | A |
| 09 Sep, 2021 | Zhilin Li | Common Stock | A | 1,760,000 | $0.67 | 55 | D | A |
| 23 Dec, 2020 | Zhilin Li | Common Stock | A | 2,000,000 | $0.00 | 48 | D | A |
| 28 Apr, 2012 | Frank Waung | - | - | 1 | D | |||
| 28 Apr, 2012 | Frank Waung | Common Stock | A | 100,000 | $0.00 | 1 | D | A |
| 25 May, 2011 | Zhilin Li | Common Stock | A | 50,000 | $0.00 | 40 | D | A |
| 25 May, 2011 | Zhilin Li | - | - | 40 | D | |||
| 25 May, 2011 | Frank Waung | Common Stock | A | 25,000 | $0.00 | 0 | D | A |
| 09 Feb, 2010 | Heung Mei Tsui | - | - | 37 | D | |||
| 09 Feb, 2010 | Heung Mei Tsui | Common Stock, par value $0.001 per share | D | 1,500,000 | $3.00 | 37 | D | A |
| 26 Nov, 2007 | Heung Mei Tsui | Common Stock, par value $0.001 per share | D | 4,465,734 | $1.52 | 43 | D | A |